Diagnostics

Mass spectrometry-based proteomics identifies progressive changes in tau PTMs over time

Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer’s

Diagnosing dementia in low educated and indigenous populations

Antibodies as research tools to study dementia

Microglia associated with longevity and a lower AD risk

The development of oligomer-specific antibodies and their potential use as a diagnostic tool

Hopes and challenges in AD research

The impact of antibodies use on biomedical research

The benefits of GWAS in understanding Alzheimer’s disease

Defining Alzheimer’s disease: clinical or biological

The role of phosphorylated tau in clinical trials

Using phosphorylated tau as a diagnostic tool for Alzheimer’s disease

Neurovascular dysfunction and Alzheimer’s disease pathology

Vascular abnormalities as a predictive precursor for Alzheimer’s disease

The importance of concordant treatment for Alzheimer’s disease and vascular health

Atypical presentation of Alzheimer’s disease in younger patients